The new drug delivery technology combines Lena’s proprietary nano-particle engineering technology with Encap’s liquid filled hard capsule technology.

Lena’s nano-particle approach results in a decrease in drug particle size, an increase in surface area therefore a faster dissolution resulting in increased bioavailability of the active drug.

Encap’s Liquid fill technology uses solutions or suspensions of drug in non-aqueous liquids to increase the drug’s bioavailability.

Encap CEO Stephen Brown said they believe that there are considerable synergies to be achieved by combining the nano-particle and liquid fill technologies particularly for low solubility and low permeability compounds.